AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor. AVEO $7.8800 0.1900 % 2.4700 Aveo Pharmaceuticals Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY […]